Safety and Efficacy of an Injectable Extracellular Matrix Hydrogel for Treating Myocardial Infarction
Top Cited Papers
- 20 February 2013
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 5 (173), 173ra25
- https://doi.org/10.1126/scitranslmed.3005503
Abstract
A hydrogel derived from myocardial extracellular matrix mitigates negative left ventricular remodeling and improves heart function after myocardial infarction in pigs.Keywords
This publication has 40 references indexed in Scilit:
- Catheter-Deliverable Hydrogel Derived From Decellularized Ventricular Extracellular Matrix Increases Endogenous Cardiomyocytes and Preserves Cardiac Function Post-Myocardial InfarctionJournal of the American College of Cardiology, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challengesActa Biomaterialia, 2011
- Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine modelProceedings of the National Academy of Sciences of the United States of America, 2010
- Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineeringBiomaterials, 2009
- Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardiumBiomaterials, 2009
- Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular componentBiomaterials, 2009
- Allogeneic Mesenchymal Precursor Cell Therapy to Limit Remodeling After Myocardial Infarction: The Effect of Cell DosageThe Annals of Thoracic Surgery, 2009
- Prognostic Value of Left Ventricular End-Systolic Volume Index as a Predictor of Heart Failure Hospitalization in Stable Coronary Artery Disease: Data from the Heart and Soul StudyJournal of the American Society of Echocardiography, 2009
- Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in PigsThe Annals of Thoracic Surgery, 2008